19-norandrostenedione

From WikiMD's Food, Medicine & Wellness Encyclopedia

19-Norandrostenedione is a steroid that is an androgen precursor. It is a prohormone of nandrolone. Until the year 2005, 19-norandrostenedione was available without prescription in United States, where it was marketed as a prohormone, but it is now classified as a Schedule III drug. It is also banned from use in many sports, including the Olympic Games, under the World Anti-Doping Agency.

Chemistry[edit | edit source]

19-Norandrostenedione is derived from androstenedione, from which it differs by the absence of a carbon atom at the 19th position. It is a precursor to nandrolone, a potent anabolic steroid.

Use in Supplements[edit | edit source]

19-Norandrostenedione was used in dietary supplements that were designed to increase the production of testosterone and muscle mass. However, the body's conversion of 19-norandrostenedione to testosterone is very low. It is more useful as a precursor to nandrolone.

Health Risks[edit | edit source]

The use of 19-norandrostenedione can lead to numerous health risks. These include liver damage, heart disease, and infertility. It can also lead to masculinization in women and gynecomastia (development of breasts) in men.

Legal Status[edit | edit source]

In the United States, 19-norandrostenedione is classified as a Schedule III drug under the Controlled Substances Act. It is also banned in many sports, including the Olympic Games, under the World Anti-Doping Agency.

See Also[edit | edit source]

‎ ‎


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD